The Commerce Department closed a year‑old loophole on Sunday, saying advanced Nvidia and AMD chips sold to companies headquartered in China now require export licenses even when bought through overseas affiliates. The move tightens export checks and could complicate shipments for Bay Area chip and data‑center firms.

Updated CHORD trial numbers presented in Seoul suggest most children with otoferlin‑related deafness gained meaningful hearing after Otarmeni treatment. The therapy was FDA‑cleared in April.

Early trial data show amivantamab shrank—and in some patients erased—tumors in treatment‑resistant head and neck cancer, with results set for ASCO on Sunday. Investigators call the responses striking but preliminary.

Foundation Future Industries says it has Pentagon research contracts to test Phantom humanoid robots and has already sent early units to Ukraine. The award and the company's ties to Eric Trump have prompted scrutiny and oversight questions.

Objectors say Bayer’s $7.25B Roundup settlement tramples due process and favors lawyers; a May removal filing and a June 4 opt‑out deadline now cloud approval.

Chicago’s Tempus won FDA clearance to run its xT CDx test without matched normal samples, a label expansion the company says will broaden use and affect reimbursement.

The White House approved roughly $9 billion to buy Nvidia superchips and build the liquid‑cooled data centers that run them, aiming to close an intelligence‑community compute gap. The move raises procurement, timing and civil‑liberties questions as agencies race to deploy frontier AI on classified networks.

Washington University researchers David Holtzman and Randall Bateman will be honored for developing the PrecivityAD blood tests that make Alzheimer’s diagnosis earlier and more accessible.

An experimental drug called bepirovirsen produced durable 'functional cures' in roughly 20% of patients in large trials, offering a potential finite therapy for chronic hepatitis B.

The FBI says a Telegram-sold phishing kit named Kali365 is capturing Microsoft 365 tokens and bypassing MFA. Security firms and Microsoft urge admins and users to tighten device-code controls.

FDA advisers will vote this week on whether to switch the 2026–27 COVID booster to target XFG, a subvariant with immune‑evasive mutations.

The Supreme Court declined to block Vermont’s consumer‑protection suit accusing Instagram of engineering features that addict teens, allowing the case to proceed. The decision follows recent state court setbacks for Meta.

Oklo says it has been picked by the DOE for talks to turn Cold War plutonium into reactor fuel while critics warn of serious proliferation and safety concerns. The company will partner with newcleo and says strict safeguards would apply.